Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
CONCLUSIONS: Factor Xa inhibitors had the highest growth in utilization during our study period, followed by aspirin, when compared with enoxaparin and warfarin. When selected for the right patient, factor Xa inhibitors provided improved VTE prophylaxis compared with enoxaparin and warfarin, with a lower rate of blood transfusion. Aspirin provided comparable VTE prophylaxis compared with factor Xa inhibitors with improved VTE prophylaxis compared with enoxaparin and warfarin with the lowest risk of bleeding.
LEVEL OF EVIDENCE: Level III, therapeutic study.
PMID: 28569372 [PubMed - as supplied by publisher]
Source: Clinical Orthopaedics and Related Research - Category: Orthopaedics Authors: Bala A, Huddleston JI, Goodman SB, Maloney WJ, Amanatullah DF Tags: Clin Orthop Relat Res Source Type: research
More News: Anemia | Aspirin | Bleeding | Blood Transusion | Coumadin | Databases & Libraries | Lovenox | Medicare | Orthopaedics | Pulmonary Thromboembolism | Statistics | Study | Thrombosis | Warfarin